Autoimmunity Reviews

Autoimmunity Reviews is an immunology review journal published by Elsevier. Founded in 2002 and appearing monthly, it carries print ISSN 1568-9972 and online ISSN 1873-0183, reports a 2025 impact factor of 9.8, and centres on structured reviews commissioned by its editors-in-chief.Autoimmunity Reviews 是爱思唯尔出版的自身免疫学综述期刊，2002 年创刊，月刊，印刷版编号 1568-9972、电子版编号 1873-0183，2025 年影响因子为 9.8，以主编约稿的结构化综述为主。^[1]

Scope

• Scope: the journal publishes up-to-date, structured reviews on diverse topics in autoimmunology, written by first-class experts in the field, with demonstrative illustrations and tables and a take-home message in every article, bridging basic and clinical sciences.学科定位： 发表自身免疫学各领域的最新结构化综述，由领域一流专家撰写，文章配有说明性插图与表格，并须给出明确的「核心要点」信息，沟通基础科学与临床研究。^[2]
• Topics: all fields of autoimmunology, the pathophysiology and mechanisms of disorders, genomics and proteomics, and diseases, novel therapies and clinical associations.收录主题： 自身免疫学各领域，疾病的病理生理与机制，基因组学与蛋白质组学，以及临床疾病、新疗法与临床关联。
• Article types: review articles, technical notes, letters to the editors and special or thematic issues.文章体裁： 综述文章、技术简报、致编辑信与专题专辑。
• Publishing model: hybrid open access, with authors choosing between an open access route carrying an article processing charge and a subscription route free of publication charges.出版模式： 混合开放获取，作者可选开放获取或订阅路径，开放获取需支付版面费。
• Indexing and metrics: covered by Scopus, Medline and the SCIE and tracked by the SJR and SNIP indicators, with a 2025 impact factor of 9.8, a CiteScore of 15.8 and roughly two days to first decision.收录与指标： 被 Scopus、Medline、SCIE 收录并计入 SJR 与 SNIP 指标，2025 年影响因子 9.8、CiteScore 15.8，投稿至首次决定约 2 天。

History

• Founded: the journal was founded in 2002 and has reached volume 25 by 2026, with volumes numbered consecutively by year and no renaming since launch.创刊： 2002 年创刊，卷号按年连续编号，2026 年为第 25 卷，创刊以来未曾更名。^[3]
• Title history: no renaming on record, the title Autoimmunity Reviews has been in use since 2002.更名史： 无更名记录，创刊至今沿用 Autoimmunity Reviews 刊名。
• Publishing background: the journal appeared at a time of rapid expansion in autoimmunity research and accelerating translation of basic immunological findings, integrating disciplinary progress in review form.出版背景： 创刊于自身免疫研究快速扩展、基础免疫学发现向临床转化加速的时期，以综述形式整合学科进展。

Editors

• Co-editors-in-chief: Andras Perl, MD PhD, of SUNY Upstate Medical University in New York, working on clinical research in autoimmune disease, and Dimitrios Bogdanos, MD PhD, of the Faculty of Medicine at the University of Thessaly in Greece, working on autoimmune liver disease.共同主编： Andras Perl，美国纽约州立大学上州医科大学医学博士与哲学博士，研究方向为自身免疫病临床研究；Dimitrios Bogdanos，希腊塞萨利大学医学院医学博士与哲学博士，研究方向为自身免疫性肝病。^[4]
• Editorial board: some 60 editorial board members, strongly international, spanning the United States, Spain, Israel, Italy, the United Kingdom, Brazil, China, Japan, Germany, France, Greece, Hungary, Latvia, Colombia, Australia and Portugal.编委构成： 编委会约 60 名成员，高度国际化，覆盖美国、西班牙、以色列、意大利、英国、巴西、中国、日本、德国、法国、希腊、匈牙利、拉脱维亚、哥伦比亚、澳大利亚与葡萄牙等。
• Submission and review: submissions go through Editorial Manager and peer review is single anonymized, with articles principally invited by the editors but submitted contributions also considered for publication.投稿与评审： 经 Editorial Manager 系统投稿，实行单盲评审；文章以约稿为主，自由投稿经评审后亦被考虑发表。
• Board composition: the official editorial board page shows a membership centred on the United States and on southern and eastern Europe, with women accounting for roughly one third of the board.编委分布： 官方编委页显示编委会成员以美国与南欧、东欧学者为主体，女性成员约占三分之一。